These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681 [TBL] [Abstract][Full Text] [Related]
6. Manipulation of Host Cell Death Pathways by Herpes Simplex Virus. He S; Han J Curr Top Microbiol Immunol; 2023; 442():85-103. PubMed ID: 32060646 [TBL] [Abstract][Full Text] [Related]
7. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Wang X; Li Y; Liu S; Yu X; Li L; Shi C; He W; Li J; Xu L; Hu Z; Yu L; Yang Z; Chen Q; Ge L; Zhang Z; Zhou B; Jiang X; Chen S; He S Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15438-43. PubMed ID: 25316792 [TBL] [Abstract][Full Text] [Related]
8. Cell-type dependence of necroptosis pathways triggered by viral infection. Koehler H; Titus D; Lawson C FEBS J; 2024 Jun; 291(11):2388-2404. PubMed ID: 38145501 [TBL] [Abstract][Full Text] [Related]
9. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Wang Z; Feng J; Yu J; Chen G J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177 [TBL] [Abstract][Full Text] [Related]
10. ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1. Solon M; Ge N; Hambro S; Haller S; Jiang J; Baca M; Preston J; Maltzman A; Wickliffe KE; Liang Y; Reja R; Nickles D; Newton K; Webster JD Cell Death Differ; 2024 May; 31(5):672-682. PubMed ID: 38548850 [TBL] [Abstract][Full Text] [Related]
11. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904 [TBL] [Abstract][Full Text] [Related]
12. ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis. Koerner L; Wachsmuth L; Kumari S; Schwarzer R; Wagner T; Jiao H; Pasparakis M Cell Death Differ; 2024 Jul; 31(7):938-953. PubMed ID: 38849574 [TBL] [Abstract][Full Text] [Related]
13. An outline of necrosome triggers. Vanden Berghe T; Hassannia B; Vandenabeele P Cell Mol Life Sci; 2016 Jun; 73(11-12):2137-52. PubMed ID: 27052312 [TBL] [Abstract][Full Text] [Related]
14. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311 [TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities. Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927 [TBL] [Abstract][Full Text] [Related]
16. Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells. Nemegeer J; Lemeire K; Vandenabeele P; Maelfait J J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342164 [TBL] [Abstract][Full Text] [Related]
17. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Rodriguez DA; Weinlich R; Brown S; Guy C; Fitzgerald P; Dillon CP; Oberst A; Quarato G; Low J; Cripps JG; Chen T; Green DR Cell Death Differ; 2016 Jan; 23(1):76-88. PubMed ID: 26024392 [TBL] [Abstract][Full Text] [Related]
18. Reconstitution of Human Necrosome Interactions in Ji Y; Ward LA; Hawkins CJ Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33503908 [TBL] [Abstract][Full Text] [Related]
19. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367 [TBL] [Abstract][Full Text] [Related]
20. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]